The Effects of Dietary Supplement of Coenzyme Q10(CoQ10) on Dyslipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT02407548
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT02407548
-
- Other papers using this trial's data
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02407548. Randomized; quadruple masking; primary purpose treatment. Start 2015-07 (actual); primary completion 2017-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effects of Dietary Supplement of Coenzyme Q10(CoQ10) on Dyslipidemia
- Acronym
- TEDSCD
- Condition
- Dyslipidemia
- Intervention (Dietary supplement)
- coenzyme Q10 vitamin E softgel
- Intervention (Dietary supplement)
- coenzyme Q10 softgel
- Intervention (Dietary supplement)
- placebo softgel
- Lead sponsor
- Sun Yat-sen University
Record details
- Record id
cardio:ct-nct02407548- Content hash
af572ba1fb8050050c1ad55bf6c24143e2643a884819c368f76cde3de2949521